About this trial
The purpose of this pilot study is to evaluate the feasibility, acceptability, and preliminary effects of an Acceptance and Commitment Therapy (ACT)-based psychosocial intervention for women who have experienced perinatal loss (miscarriage, stillbirth, or neonatal death). The intervention is a 4-week programme delivered in a mixed format: four in-person sessions (hospital setting, one-on-two with spouse/significant other) and two videoconferencing sessions (post-discharge, one-on-one), plus a 30-minute booster session one month after completion. Outcome assessments will occur at baseline (pre-intervention), immediately post-intervention, and three months post-intervention. Primary feasibility and acceptability metrics include recruitment, retention, session attendance, and participant-rated satisfaction. Preliminary effectiveness outcomes include perinatal grief, post-traumatic stress, depression, anxiety, psychological flexibility, and perceived social support. A qualitative component (semi-structured interviews) will explore participants' experiences and suggestions for refinement.
Eligibility criteria
Qualifiers
Women aged ≥18 years
Experienced perinatal loss (including miscarriage, stillbirth, or early neonatal death) within the past 12 months
Spouse/partner willing to participate throughout the entire study
Able to read and communicate in Chinese
Disqualifiers
Current diagnosis of severe mental illness (e.g., schizophrenia, bipolar disorder acute episode, psychotic disorder)
Active suicidal ideation with plan or intent, as assessed by clinical judgment or PHQ-9 item 9 score ≥1
Concurrent participation in other systematic psychotherapy or psychosocial intervention
Cognitive impairment that precludes understanding of the intervention content
Trial design
Treatments tested in this trial
- Acceptance and Commitment Therapy